82_FR_8541 82 FR 8525 - Proposed Data Collection Submitted for Public Comment and Recommendations

82 FR 8525 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry

Federal Register Volume 82, Issue 16 (January 26, 2017)

Page Range8525-8527
FR Document2017-01741

The Agency for Toxic Substances and Disease Registry (ATSDR), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on ``Cognition, Behavior, and Caregiver Burden in Amyotrophic Lateral Sclerosis (ALS).'' Measures of ALS severity, cognition, mood and behavior, and caregiver burden will be completed by telephone and by mail.

Federal Register, Volume 82 Issue 16 (Thursday, January 26, 2017) 
[Federal Register Volume 82, Number 16 (Thursday, January 26, 2017)]
[Notices]
[Pages 8525-8527]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-01741]



[[Page 8525]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Toxic Substances and Disease Registry

[60 Day-17-17KN; Docket No. ATSDR-2017-0001]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), 
Department of Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR), 
as part of its continuing efforts to reduce public burden and maximize 
the utility of government information, invites the general public and 
other Federal agencies to take this opportunity to comment on proposed 
and/or continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on ``Cognition, 
Behavior, and Caregiver Burden in Amyotrophic Lateral Sclerosis 
(ALS).'' Measures of ALS severity, cognition, mood and behavior, and 
caregiver burden will be completed by telephone and by mail.

DATES: Written comments must be received on or before March 27, 2017.

ADDRESSES: You may submit comments, identified by Docket No. ATSDR-
2017-0001 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Cognition, Behavior, and Caregiver Burden in Amyotrophic Lateral 
Sclerosis (ALS)--New--Agency for Toxic Substances and Disease Registry 
(ATSDR).

Background and Brief Description

    The Agency for Toxic Substances and Disease Registry (ATSDR) is 
requesting a two-year clearance for a new information collection 
request (ICR) titled ``Cognition, Behavior, and Caregiver Burden in 
Amyotrophic Lateral Sclerosis (ALS).'' ATSDR awarded funds to Boston 
Veterans Affairs Research Institute (BVARI) through a contract (200-
2014-59030) to conduct this study. This new information collection will 
enhance the scientific value of the ATSDR's National ALS Registry (OMB 
Control No. 0923-0041; expiration 11/30/2019) and focus on two topic 
areas: (a) Risk factors for ALS and (b) the burden that ALS places on 
persons with ALS (PALS), their family and caregivers, and whether these 
relationships affect ALS disease progression over a 1-year interval.
    ALS is an adult-onset, rapidly fatal, neurodegenerative disease of 
unknown etiology that has been linked to genetic and environmental risk 
factors. Although ALS is primarily a motor neuron disease, there is a 
growing consensus about impaired cognitive function and behavioral 
disturbance in the disease, with prevalence estimates ranging from 10-
75 percent for cognitive and behavioral disturbance and 15-41 percent 
for dementia. Cognitive and behavioral dysfunction in PALS is 
associated with shorter survival, and, perhaps, ALS disease 
progression. Research reported demonstrates that there is scarce 
information on risk factors for developing specific cognitive and 
behavioral ALS subtypes and whether these subtypes represent a 
continuum of cognitive and behavioral impairment associated with ALS 
disease progression. Better understanding of ALS subtypes and caregiver 
burden will provide crucial insights into the risk factors for and 
pathophysiology of the disease and caregiver burden.
    This is a prospective study. A national sample of PALS and their 
caregivers (dyads) will be recruited from the ATSDR National ALS 
Registry to study the following aims:
    1. Characterize the cognitive/behavioral subtypes in a large 
national cohort of PALS and identify risk factors for these subtypes;
    2. Study cross-sectional and longitudinal relationships among 
cognitive/behavioral subtypes in PALS and caregiver giver burden, and 
whether these relationships affect ALS disease progression over a one 
year interval.

[[Page 8526]]

    The study sample will be composed of men and women with ALS and 
their caregivers (i.e., patient/caregiver dyads) from across the U.S. 
All patient enrollees will have a diagnosis of possible, probable or 
definite ALS according to the El Escorial World Federation of Neurology 
criteria for the diagnosis of ALS. Examining the effects of cognitive 
and mood changes in PALS on disease progression and caregiver burden 
may illustrate new ways to slow the rapid progression of the disease 
and develop better coping strategies to help caregivers provide 
effective care for longer periods.
    Data will be collected on ALS severity, cognition, mood and 
behavior, and caregiver burden measures will be completed by telephone 
or by mail. In PALS, measures of ALS severity, cognition, and mood and 
behavior will be collected at baseline and at follow-up one year 
thereafter. In caregivers, measures related to caregiver burden will be 
collected at baseline and every 6 months thereafter. Furthermore, 
caregivers may be asked to complete additional measures if PALS are 
unable, including cognition of PALS and ALS severity in PALS at 
baseline and annual follow-up.
    We estimate that 1,500 PALS/caregiver dyads will be screened for 
recruitment and 300 dyads will be enrolled. In addition, the 300 
caregivers will respond for themselves. Participation in the study is 
voluntary and there are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per    of response    Total burden
                                                    respondents     respondent      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Persons with ALS (PALS) and     Recruitment and            1,500               1           30/60             750
 caregiver dyads.                Enrollment
                                 Telephone
                                 Script.
Person with ALS...............  ALS Functional               150               2           30/60             150
                                 Rating Score--
                                 Extended
                                 Edition (ALSFRS-
                                 EX).
                                Telephone                    150               2           20/60             100
                                 Interview for
                                 Cognitive
                                 Status-modified
                                 (TICSm).
                                ALS Cognitive                150               2           15/60              75
                                 Behavioral
                                 Screen (ALS-
                                 CBS).
                                Primary Care                 150               2           10/60              50
                                 Evaluation of
                                 Mental
                                 Disorders
                                 Patient Health
                                 Questionnaire
                                 (PRIME-MD PHQ).
                                Beck Depression              150               2           10/60              50
                                 Inventory-II
                                 (BDI-II).
                                Beck                         150               2            5/60              25
                                 Hopelessness
                                 Scale (BHS).
                                Dysexecutive                 150               2           10/60              50
                                 Questionnaire
                                 (DEX).
Caregiver proxy for person      ALS Functional               150               2           30/60             150
 with ALS (PALS).                Rating Score--
                                 Extended
                                 Edition (ALSFRS-
                                 EX).
                                Primary Care                 150               2           10/60              50
                                 Evaluation of
                                 Mental
                                 Disorders
                                 Patient Health
                                 Questionnaire
                                 (PRIME-MD PHQ).
                                Beck Depression              150               2           10/60              50
                                 Inventory-II
                                 (BDI-II).
                                Beck                         150               2            5/60              25
                                 Hopelessness
                                 Scale (BHS).
                                Dysexecutive                 150               2           10/60              50
                                 Questionnaire
                                 (DEX).
                                Cambridge                    150               2           10/60              50
                                 Behavioural
                                 Inventory
                                 Revised (CBI-R).
Caregiver of person with ALS    Primary Care                 300               2           10/60             100
 (PALS).                         Evaluation of
                                 Mental
                                 Disorders
                                 Patient Health
                                 Questionnaire
                                 (PRIME-MD PHQ).
                                Beck Depression              300               3           10/60             150
                                 Inventory-II
                                 (BDI-II).
                                Beck                         300               3            5/60              75
                                 Hopelessness
                                 Scale (BHS).
                                Dysexecutive                 300               2           10/60             100
                                 Questionnaire
                                 (DEX).
                                Zarit Burden                 300               3           10/60             150
                                 Interview (ZBI).
                                Social Support               300               3           10/60             150
                                 Questionnaire
                                 Short Form
                                 (SSQSF).
                                Kosberg Cost of              300               3            5/60              75
                                 Care Index.
                                ALS Cognitive                300               3            5/60              75
                                 Behavioral
                                 Screen (ALS-
                                 CBS)--Caregiver
                                 portion.
                                Brief COPE......             300               3           10/60             150
                                Perceived Stress             300               3            5/60              75
                                 Scale (PSS).
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           2,725
----------------------------------------------------------------------------------------------------------------



[[Page 8527]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-01741 Filed 1-25-17; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices 8525 DEPARTMENT OF HEALTH AND Collection Review Office, Centers for Toxic Substances and Disease Registry HUMAN SERVICES Disease Control and Prevention, 1600 (ATSDR). Clifton Road NE., MS–D74, Atlanta, Agency for Toxic Substances and Background and Brief Description Georgia 30329; phone: 404–639–7570; Disease Registry Email: omb@cdc.gov. The Agency for Toxic Substances and [60 Day–17–17KN; Docket No. ATSDR– Disease Registry (ATSDR) is requesting SUPPLEMENTARY INFORMATION: Under the a two-year clearance for a new 2017–0001] Paperwork Reduction Act of 1995 (PRA) information collection request (ICR) (44 U.S.C. 3501–3520), Federal agencies titled ‘‘Cognition, Behavior, and Proposed Data Collection Submitted must obtain approval from the Office of Caregiver Burden in Amyotrophic for Public Comment and Management and Budget (OMB) for each Lateral Sclerosis (ALS).’’ ATSDR Recommendations collection of information they conduct awarded funds to Boston Veterans AGENCY: Agency for Toxic Substances or sponsor. In addition, the PRA also Affairs Research Institute (BVARI) and Disease Registry (ATSDR), requires Federal agencies to provide a through a contract (200–2014–59030) to Department of Health and Human 60-day notice in the Federal Register conduct this study. This new Services (HHS). concerning each proposed collection of information collection will enhance the ACTION: Notice with comment period. information, including each new scientific value of the ATSDR’s National proposed collection, each proposed ALS Registry (OMB Control No. 0923– SUMMARY: The Agency for Toxic extension of existing collection of 0041; expiration 11/30/2019) and focus Substances and Disease Registry information, and each reinstatement of on two topic areas: (a) Risk factors for (ATSDR), as part of its continuing previously approved information ALS and (b) the burden that ALS places efforts to reduce public burden and collection before submitting the on persons with ALS (PALS), their maximize the utility of government collection to OMB for approval. To family and caregivers, and whether information, invites the general public comply with this requirement, we are these relationships affect ALS disease and other Federal agencies to take this publishing this notice of a proposed progression over a 1-year interval. opportunity to comment on proposed data collection as described below. ALS is an adult-onset, rapidly fatal, and/or continuing information Comments are invited on: (a) Whether neurodegenerative disease of unknown collections, as required by the the proposed collection of information etiology that has been linked to genetic Paperwork Reduction Act of 1995. This is necessary for the proper performance and environmental risk factors. notice invites comment on ‘‘Cognition, of the functions of the agency, including Although ALS is primarily a motor Behavior, and Caregiver Burden in whether the information shall have neuron disease, there is a growing Amyotrophic Lateral Sclerosis (ALS).’’ practical utility; (b) the accuracy of the consensus about impaired cognitive Measures of ALS severity, cognition, agency’s estimate of the burden of the function and behavioral disturbance in mood and behavior, and caregiver proposed collection of information; (c) the disease, with prevalence estimates burden will be completed by telephone ways to enhance the quality, utility, and ranging from 10–75 percent for and by mail. clarity of the information to be cognitive and behavioral disturbance DATES: Written comments must be collected; (d) ways to minimize the and 15–41 percent for dementia. received on or before March 27, 2017. burden of the collection of information Cognitive and behavioral dysfunction in ADDRESSES: You may submit comments, on respondents, including through the PALS is associated with shorter identified by Docket No. ATSDR–2017– use of automated collection techniques survival, and, perhaps, ALS disease 0001 by any of the following methods: or other forms of information progression. Research reported • Federal eRulemaking Portal: technology; and (e) estimates of capital demonstrates that there is scarce Regulations.gov. Follow the instructions or start-up costs and costs of operation, information on risk factors for for submitting comments. maintenance, and purchase of services developing specific cognitive and • Mail: Leroy A. Richardson, to provide information. Burden means behavioral ALS subtypes and whether Information Collection Review Office, the total time, effort, or financial these subtypes represent a continuum of Centers for Disease Control and resources expended by persons to cognitive and behavioral impairment Prevention, 1600 Clifton Road NE., MS– generate, maintain, retain, disclose or associated with ALS disease D74, Atlanta, Georgia 30329. provide information to or for a Federal progression. Better understanding of Instructions: All submissions received agency. This includes the time needed ALS subtypes and caregiver burden will must include the agency name and to review instructions; to develop, provide crucial insights into the risk Docket Number. All relevant comments acquire, install and utilize technology factors for and pathophysiology of the received will be posted without change and systems for the purpose of disease and caregiver burden. to Regulations.gov, including any collecting, validating and verifying This is a prospective study. A personal information provided. For information, processing and national sample of PALS and their access to the docket to read background maintaining information, and disclosing caregivers (dyads) will be recruited from documents or comments received, go to and providing information; to train the ATSDR National ALS Registry to Regulations.gov. personnel and to be able to respond to study the following aims: Please note: All public comment a collection of information, to search 1. Characterize the cognitive/ should be submitted through the data sources, to complete and review behavioral subtypes in a large national Federal eRulemaking portal the collection of information; and to cohort of PALS and identify risk factors jstallworth on DSK7TPTVN1PROD with NOTICES (Regulations.gov) or by U.S. mail to the transmit or otherwise disclose the for these subtypes; address listed above. information. 2. Study cross-sectional and FOR FURTHER INFORMATION CONTACT: To Proposed Project longitudinal relationships among request more information on the cognitive/behavioral subtypes in PALS proposed project or to obtain a copy of Cognition, Behavior, and Caregiver and caregiver giver burden, and whether the information collection plan and Burden in Amyotrophic Lateral these relationships affect ALS disease instruments, contact the Information Sclerosis (ALS)—New—Agency for progression over a one year interval. VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1

8526 Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices The study sample will be composed develop better coping strategies to help caregivers may be asked to complete of men and women with ALS and their caregivers provide effective care for additional measures if PALS are unable, caregivers (i.e., patient/caregiver dyads) longer periods. including cognition of PALS and ALS from across the U.S. All patient Data will be collected on ALS severity in PALS at baseline and annual enrollees will have a diagnosis of severity, cognition, mood and behavior, follow-up. possible, probable or definite ALS and caregiver burden measures will be completed by telephone or by mail. In We estimate that 1,500 PALS/ according to the El Escorial World caregiver dyads will be screened for Federation of Neurology criteria for the PALS, measures of ALS severity, cognition, and mood and behavior will recruitment and 300 dyads will be diagnosis of ALS. Examining the effects enrolled. In addition, the 300 caregivers be collected at baseline and at follow-up of cognitive and mood changes in PALS will respond for themselves. one year thereafter. In caregivers, on disease progression and caregiver measures related to caregiver burden Participation in the study is voluntary burden may illustrate new ways to slow will be collected at baseline and every and there are no costs to respondents the rapid progression of the disease and 6 months thereafter. Furthermore, other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Average Number of Number of burden of Total burden Type of respondents Form name responses per respondents response hours respondent (in hours) Persons with ALS (PALS) Recruitment and Enrollment Telephone 1,500 1 30/60 750 and caregiver dyads. Script. Person with ALS ................... ALS Functional Rating Score—Extended 150 2 30/60 150 Edition (ALSFRS–EX). Telephone Interview for Cognitive Status- 150 2 20/60 100 modified (TICSm). ALS Cognitive Behavioral Screen (ALS– 150 2 15/60 75 CBS). Primary Care Evaluation of Mental Dis- 150 2 10/60 50 orders Patient Health Questionnaire (PRIME–MD PHQ). Beck Depression Inventory-II (BDI–II) ......... 150 2 10/60 50 Beck Hopelessness Scale (BHS) ................ 150 2 5/60 25 Dysexecutive Questionnaire (DEX) ............. 150 2 10/60 50 Caregiver proxy for person ALS Functional Rating Score—Extended 150 2 30/60 150 with ALS (PALS). Edition (ALSFRS–EX). Primary Care Evaluation of Mental Dis- 150 2 10/60 50 orders Patient Health Questionnaire (PRIME–MD PHQ). Beck Depression Inventory-II (BDI–II) ......... 150 2 10/60 50 Beck Hopelessness Scale (BHS) ................ 150 2 5/60 25 Dysexecutive Questionnaire (DEX) ............. 150 2 10/60 50 Cambridge Behavioural Inventory Revised 150 2 10/60 50 (CBI–R). Caregiver of person with ALS Primary Care Evaluation of Mental Dis- 300 2 10/60 100 (PALS). orders Patient Health Questionnaire (PRIME–MD PHQ). Beck Depression Inventory-II (BDI–II) ......... 300 3 10/60 150 Beck Hopelessness Scale (BHS) ................ 300 3 5/60 75 Dysexecutive Questionnaire (DEX) ............. 300 2 10/60 100 Zarit Burden Interview (ZBI) ......................... 300 3 10/60 150 Social Support Questionnaire Short Form 300 3 10/60 150 (SSQSF). Kosberg Cost of Care Index ........................ 300 3 5/60 75 ALS Cognitive Behavioral Screen (ALS– 300 3 5/60 75 CBS)—Caregiver portion. Brief COPE ................................................... 300 3 10/60 150 Perceived Stress Scale (PSS) ..................... 300 3 5/60 75 Total ............................... ....................................................................... ........................ ........................ ........................ 2,725 jstallworth on DSK7TPTVN1PROD with NOTICES VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00024 Fmt 4703 Sfmt 9990 E:\FR\FM\26JAN1.SGM 26JAN1

Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices 8527 Leroy A. Richardson, Prevention, 1600 Clifton Road NE., MS– technology; and (e) estimates of capital Chief, Information Collection Review Office, D74, Atlanta, Georgia 30329. or start-up costs and costs of operation, Office of Scientific Integrity, Office of the Instructions: All submissions received maintenance, and purchase of services Associate Director for Science, Office of the must include the agency name and to provide information. Burden means Director, Centers for Disease Control and Docket Number. All relevant comments the total time, effort, or financial Prevention. received will be posted without change resources expended by persons to [FR Doc. 2017–01741 Filed 1–25–17; 8:45 am] to Regulations.gov, including any generate, maintain, retain, disclose or BILLING CODE 4163–18–P personal information provided. For provide information to or for a Federal access to the docket to read background agency. This includes the time needed documents or comments received, go to to review instructions; to develop, DEPARTMENT OF HEALTH AND Regulations.gov. acquire, install and utilize technology HUMAN SERVICES Please note: All public comment and systems for the purpose of should be submitted through the collecting, validating and verifying Centers for Disease Control and Federal eRulemaking portal information, processing and Prevention (Regulations.gov) or by U.S. mail to the maintaining information, and disclosing [60Day–17–0006; Docket No. CDC–2017– address listed above. and providing information; to train 0004] FOR FURTHER INFORMATION CONTACT: To personnel and to be able to respond to request more information on the a collection of information, to search Proposed Data Collection Submitted data sources, to complete and review for Public Comment and proposed project or to obtain a copy of the information collection plan and the collection of information; and to Recommendations transmit or otherwise disclose the instruments, contact the Information AGENCY: Centers for Disease Control and Collection Review Office, Centers for information. Prevention (CDC), Department of Health Disease Control and Prevention, 1600 Proposed Project and Human Services (HHS). Clifton Road NE., MS–D74, Atlanta, ACTION: Notice with comment period. Georgia 30329; phone: 404–639–7570; Statements in Support of Application Email: omb@cdc.gov. of Waiver of Inadmissibility (OMB SUMMARY: The Centers for Disease SUPPLEMENTARY INFORMATION: Control No. 0920–0006; Expires 8/31/ Control and Prevention (CDC), as part of Under the Paperwork Reduction Act 2017)—Extension—National Center for its continuing efforts to reduce public of 1995 (PRA) (44 U.S.C. 3501–3520), Emerging and Zoonotic Infectious burden and maximize the utility of Federal agencies must obtain approval Diseases (NCEZID), Centers for Disease government information, invites the from the Office of Management and Control and Prevention (CDC). general public and other Federal Budget (OMB) for each collection of Background and Brief Description agencies to take this opportunity to information they conduct or sponsor. In comment on proposed and/or addition, the PRA also requires Federal Section 212(a)(1) of the Immigration continuing information collections, as agencies to provide a 60-day notice in and Nationality Act states that aliens required by the Paperwork Reduction the Federal Register concerning each with specific health related conditions Act of 1995. This notice invites proposed collection of information, are ineligible for admission into the comment on an extension request for including each new proposed United States. The Attorney General the information collection titled collection, each proposed extension of may waive application of this ‘‘Statements in Support of Application existing collection of information, and inadmissibility on health-related of Waiver of Inadmissibility.’’ Approved each reinstatement of previously grounds if an application for waiver is under Office of Management and Budget approved information collection before filed and approved by the consular (OMB) Control Number 0920–0006, this submitting the collection to OMB for office considering the application for information collection allows CDC to approval. To comply with this visa. CDC uses this application review Class A medical waiver requirement, we are publishing this primarily to collect information to applications for prospective immigrants notice of a proposed data collection as establish and maintain records of waiver to the United States. CDC assists DHS/ described below. applicants in order to notify the U.S. USCIS in determining whether or not a Comments are invited on: (a) Whether Citizenship and Immigration Services prospective immigrant with a Class A the proposed collection of information when terms, conditions and controls mental health designation may be is necessary for the proper performance imposed by waiver are not met. admitted into the United States. of the functions of the agency, including CDC is requesting approval from OMB DATES: Written comments must be whether the information shall have to collect this data for another three received on or before March 27, 2017. practical utility; (b) the accuracy of the years. Based on a review of the number ADDRESSES: You may submit comments, agency’s estimate of the burden of the of waivers processed by CDC over the identified by Docket No. CDC–2017– proposed collection of information; (c) last three years, CDC does not request a 0004 by any of the following methods: ways to enhance the quality, utility, and change in the amount of burden. • Federal eRulemaking Portal: clarity of the information to be Respondents must mail these Regulations.gov. Follow the instructions collected; (d) ways to minimize the documents to CDC, and this entails an for submitting comments. burden of the collection of information additional cost. CDC estimates that • Mail: Leroy A. Richardson, on respondents, including through the respondents will spend approximately jstallworth on DSK7TPTVN1PROD with NOTICES Information Collection Review Office, use of automated collection techniques $15 per year on postal fees, for a total Centers for Disease Control and or other forms of information of $3,000 annually. VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1


Document Created: 2017-01-26 00:04:57
Document Modified: 2017-01-26 00:04:57
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesWritten comments must be received on or before March 27, 2017.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS- D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation82 FR 8525 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR